Academic Calendar 2023-2024

Search Results

PATH 826 The Molecular Basis Of Disease

PATH 826  The Molecular Basis Of Disease  Units: 3.00  

This course covers several diseases that highlight the genetic, biochemical, physiologic, anatomic, and general etiologic factors that play a role in the progression of each disease from its inception to death or recovery. Some of the topics will be drawn from the ongoing research within the Department of Pathology and Molecular Medicine. The perspective will demonstrate that each disease is the result of an evolving interplay of genetic and environmental factors. (Jointly with PATH-430*. Additional work prescribed for graduate students.) Half-course, lectures and seminars; Winter term. D. Lillicrap.

Requirements: PATH410 OR ANAT311 OR BCHM310 OR PHGY312  
Offering Faculty: Faculty of Health Sciences  

Pathology and Molecular Medicine

Pathology is a study of disease and the mechanisms leading to injury. It involves a wide range of biochemical, molecular, cellular and clinical approaches. Fields of interest in the department include: cancer biology, drug resistance, metastasis, programmed cell death and cell cycle regulation, transgenic mouse models of gene function, cell differentiation and gene regulation, hemostasis/thrombosis, amyloidosis and Alzheimer's disease, disturbances in protein synthesis, and human genetics (including human gene mapping). Detailed information on faculty research interests is presented in a brochure which is available on request. See also the Department of Pathology WEB Page: .

Pathology and Molecular Medicine (PATH)

PATH 822 Experimental Cancer Therapeutics Intended for students engaged or interested in pre-clinical cancer research. Both medical and basic science trainees are encouraged to take this course. Specific areas to be covered include introduction to new drug development, molecular basis of oncogenic transformation and signalling pathways, challenges with current cancer therapeutics, molecular approaches to profiling human cancers as tools for identifying biochemical and genetic abnormalities and developing criteria for reliable prognostic indicators; strategies for novel target and drug discovery, as well as experimental drug delivery; novel imaging approaches to enhance the sensitivity of preclinical testing and selection of responsive patients; preclinical (in vitro and animal) models for validating experimental targets; clinical drug development and testing of novel anti-cancer drugs; and the molecular basis for variability in tumour responses. Half course, lectures and seminars.  PREREQUISITES: Recommended courses: ANAT 311, BCHM 310, PHAR 340, MICR 360, PATH 310, CANC 440, or equivalents, or with permission of the department. The number of students may be restricted.

Rehabilitation Science

...815, 822, 825, 824, 826 and 921 are...prepare for future career paths. (Pass/Fail). Fall...

Rehabilitation Science (RHBS)

...815, 822, 825, 824, 826 and 921 are...prepare for future career paths. (Pass/Fail). Fall...